CL2021000495A1 - Nueva formulación tópica para aplicación intradérmica y usos de la misma - Google Patents

Nueva formulación tópica para aplicación intradérmica y usos de la misma

Info

Publication number
CL2021000495A1
CL2021000495A1 CL2021000495A CL2021000495A CL2021000495A1 CL 2021000495 A1 CL2021000495 A1 CL 2021000495A1 CL 2021000495 A CL2021000495 A CL 2021000495A CL 2021000495 A CL2021000495 A CL 2021000495A CL 2021000495 A1 CL2021000495 A1 CL 2021000495A1
Authority
CL
Chile
Prior art keywords
topical formulation
intradermal application
new topical
intradermal
new
Prior art date
Application number
CL2021000495A
Other languages
English (en)
Inventor
Hakon Hakonarson
Charlly Kao
Edward T Kisak
John M Newsam
Avadhesh S Kushwaha
Original Assignee
Arctic Therapeutics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arctic Therapeutics Llc filed Critical Arctic Therapeutics Llc
Publication of CL2021000495A1 publication Critical patent/CL2021000495A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invención proporciona composiciones que comprenden una formulación tópica de donepezilo y métodos de uso de las mismas para aplicaciones intradérmicas.
CL2021000495A 2018-08-31 2021-02-26 Nueva formulación tópica para aplicación intradérmica y usos de la misma CL2021000495A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862725653P 2018-08-31 2018-08-31

Publications (1)

Publication Number Publication Date
CL2021000495A1 true CL2021000495A1 (es) 2021-09-20

Family

ID=69644782

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2021000495A CL2021000495A1 (es) 2018-08-31 2021-02-26 Nueva formulación tópica para aplicación intradérmica y usos de la misma

Country Status (10)

Country Link
US (1) US20210251973A1 (es)
EP (1) EP3843732A4 (es)
JP (1) JP2022501418A (es)
KR (1) KR20210053946A (es)
AU (1) AU2019330022A1 (es)
BR (1) BR112021003623A2 (es)
CA (1) CA3110496A1 (es)
CL (1) CL2021000495A1 (es)
SG (1) SG11202101309WA (es)
WO (1) WO2020047205A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021189077A1 (en) * 2020-03-18 2021-09-23 Chemistryrx Methods for treating acne

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6024980A (en) * 1996-06-28 2000-02-15 Mcneil-Ppc, Inc. Multiphase soft gelatin dosage form
US9186345B2 (en) * 2004-10-12 2015-11-17 Hakon Hakonarson Method of treating skin diseases
US8492503B2 (en) * 2008-09-11 2013-07-23 Nektar Therapeutics Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method
NZ605352A (en) * 2010-06-30 2013-10-25 Nal Pharmaceuticals Ltd Process for producing glycosaminoglycans
WO2016209982A1 (en) * 2015-06-22 2016-12-29 Corium International, Inc. Transdermal adhesive composition comprising a poorly soluble therapeutic agent
US11786480B2 (en) * 2015-12-10 2023-10-17 KM Transderm Ltd. Transdermally absorbable preparation
RU2762896C2 (ru) * 2016-12-20 2021-12-23 Лтс Ломанн Терапи-Систем Аг Трансдермальная терапевтическая система, содержащая азенапин

Also Published As

Publication number Publication date
WO2020047205A1 (en) 2020-03-05
SG11202101309WA (en) 2021-03-30
JP2022501418A (ja) 2022-01-06
US20210251973A1 (en) 2021-08-19
KR20210053946A (ko) 2021-05-12
BR112021003623A2 (pt) 2021-05-18
EP3843732A4 (en) 2022-05-25
EP3843732A1 (en) 2021-07-07
AU2019330022A1 (en) 2021-05-06
CA3110496A1 (en) 2020-03-05

Similar Documents

Publication Publication Date Title
CL2019003627A1 (es) Anticuerpos anti-pd-1 y sus usos. (solicitud divisional 201900628)
CL2019000793A1 (es) Moduladores de calpaínas y usos terapéuticos de los mismos.
CL2020000075A1 (es) Carboxamidas como moduladores de los canales de sodio.
CO2020007244A2 (es) Inhibidores de kras g12c
CL2020000281A1 (es) Anticuerpos anti-cd39, composiciones que comprenden anticuerpos anti-cd39 y métodos de uso de anticuerpos anti-cd39
UY38403A (es) Moduladores de la alfa-1 antitripsina
SV2018005643A (es) Composiciones de insulina de rapida accion
CO2018008207A2 (es) Composiciones para el cuidado bucal y métodos para utilizar las composiciones
BR112018005747A2 (pt) composições para higiene bucal e métodos de uso.
CO2021013339A2 (es) Degradadores de stat y usos de los mismos
UY36723A (es) Composiciones antifúngicas de methylobacterium y sus métodos de uso
BR112017020483A2 (pt) composições de microalga e usos das mesmas
BR112018005753A2 (pt) composições para higiene bucal e métodos de uso.
UY36248A (es) ?una dispersión a base de agua o aceite, formulaciones y método para prepararlas, y uso de las dispersiones o formulaciones?.
CO2018008304A2 (es) Compuestos antiproliferativos y sus composiciones farmacéuticas y usos
CL2019002605A1 (es) Formulaciones que contienen proteínas de unión pd-1 y métodos de fabricación de las mismas.
CO2022008662A2 (es) Degradadores de smarca y usos de los mismos
IT201600068623A1 (it) “use of a lignin fraction as an anti-phytopathogenic agent and anti-phytopathogenic compositions comprising the same” / “uso di una frazione di lignina come agente antifitopatogenico e composizioni antifitopatogeniche che la comprendono”
CL2019001053A1 (es) Formulaciones farmacéuticas y métodos para prepararlas.
DOP2018000066A (es) Compuestos útiles para inhibir ror-gamma-t
BR112017012818A2 (pt) fixador.
UY37342A (es) Combinación de un inhibidor de bcl-2 y un inhibidor de mcl1, usos y composiciones farmacéuticas de éstos
CL2023000491A1 (es) Composiciones de erenumab y usos de las mismas (divisional de solicitud n° 02519-2020).
BR112021011124A2 (pt) Anelossomos e métodos de uso
CL2021000495A1 (es) Nueva formulación tópica para aplicación intradérmica y usos de la misma